Manufacturer
Janssen Biotech
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 38
- Molecules
- 17
- Therapy areas
- 2
Janssen Biotech is a pharmaceutical manufacturer based in United States. MedsAcross lists 38 of its products across 17 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Janssen Biotech, Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Janssen Biotech products through licensed channels, with the documents your regulator needs.
Immunology and transplant
17 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Icotyde 200 mg tabletOral | Icotrokinra | US FDA | Available on request |
| Imaavy 1202.5 mg/6.5 mL injectionIntravenous Cold chain | Nipocalimab | US FDA | Available on request |
| Imaavy 299.7 mg/1.62 mL injectionIntravenous Cold chain | Nipocalimab | US FDA | Available on request |
| Infliximab 100 mg/10 mL powder for injectionIntravenous Cold chainGeneric name | Infliximab | US FDA | Available on request |
| Remicade 100 mg/10 mL powder for injectionIntravenous Cold chain | Infliximab | US FDA | Available on request |
| Simponi 100 mg/1 mL injectionSubcutaneous Cold chain | Golimumab | US FDA | Available on request |
| Simponi 50 mg/0.5 mL injectionSubcutaneous Cold chain | Golimumab | US FDA | Available on request |
| Simponi Aria 50 mg/4 mL injectionIntravenous Cold chain | Golimumab | US FDA | Available on request |
| Stelara 130 mg/26 mL injectionIntravenous Cold chain | Ustekinumab | US FDA | Available on request |
| Stelara 45 mg/0.5 mL injectionSubcutaneous Cold chain | Ustekinumab | US FDA | Available on request |
| Stelara 90 mg/1 mL injectionSubcutaneous Cold chain | Ustekinumab | US FDA | Available on request |
| Tremfya 100 mg/1 mL injectionSubcutaneous Cold chain | Guselkumab | US FDA | Available on request |
| Tremfya 200 mg/2 mL injectionSubcutaneous Cold chain | Guselkumab | US FDA | Available on request |
| Tremfya 200 mg/20 mL injectionIntravenous Cold chain | Guselkumab | US FDA | Available on request |
| Ustekinumab 130 mg/26 mL injectionIntravenous Cold chainGeneric name | Ustekinumab | US FDA | Available on request |
| Ustekinumab 45 mg/0.5 mL injectionSubcutaneous Cold chainGeneric name | Ustekinumab | US FDA | Available on request |
| Ustekinumab 90 mg/1 mL injectionSubcutaneous Cold chainGeneric name | Ustekinumab | US FDA | Available on request |
Oncology
16 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Akeega 500 mg/100 mg tabletOral | Abiraterone and Niraparib | US FDA | Available on request |
| Akeega 500 mg/50 mg tabletOral | Abiraterone and Niraparib | US FDA | Available on request |
| Carvykti 100000000 injectable suspensionIntravenous Cold chain | Ciltacabtagene autoleucel | US FDA | Available on request |
| Darzalex 100 mg/5 mL injectionIntravenous Cold chain | Daratumumab | US FDA | Available on request |
| Darzalex IV 100 mg/5 mL injectionIntravenous Cold chain | Daratumumab | US FDA | Available on request |
| Darzalex IV 400 mg/20 mL injectionIntravenous Cold chain | Daratumumab | US FDA | Available on request |
| Inlexzo 225 mg transdermal systemIntravesical | Gemcitabine | US FDA | Available on request |
| Lazcluze 240 mg tabletOral | Lazertinib | US FDA | Available on request |
| Lazcluze 80 mg tabletOral | Lazertinib | US FDA | Available on request |
| Rybrevant 350 mg injectionIntravenous Cold chain | Amivantamab | US FDA | Available on request |
| Talvey 3 mg/1.5 mL injectionSubcutaneous Cold chain | Talquetamab | US FDA | Available on request |
| Talvey 40 mg/1 mL injectionSubcutaneous Cold chain | Talquetamab | US FDA | Available on request |
| Tecvayli 153 mg/1.7 mL injectionSubcutaneous Cold chain | Teclistamab | US FDA | Available on request |
| Tecvayli 30 mg/3 mL injectionSubcutaneous Cold chain | Teclistamab | US FDA | Available on request |
| Zytiga 250 mg tabletOral | Abiraterone | US FDA | Available on request |
| Zytiga 500 mg tabletOral | Abiraterone | US FDA | Available on request |
Other products
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Darzalex Faspro 1800 mg/30000 units per 15 mL injectionSubcutaneous Cold chain | Daratumumab and Hyaluronidase (human recombinant) | US FDA | Available on request |
| Rybrevant Faspro 1600 mg/20000 mg per 10 mL injectionSubcutaneous Cold chain | Amivantamab and Hyaluronidase (human recombinant) | US FDA | Available on request |
| Rybrevant Faspro 2240 mg/28000 mg per 14 mL injectionSubcutaneous Cold chain | Amivantamab and Hyaluronidase (human recombinant) | US FDA | Available on request |
| Rybrevant Faspro 2400 mg/30000 mg per 15 mL injectionSubcutaneous Cold chain | Amivantamab and Hyaluronidase (human recombinant) | US FDA | Available on request |
| Rybrevant Faspro 3520 mg/44000 mg per 22 mL injectionSubcutaneous Cold chain | Amivantamab and Hyaluronidase (human recombinant) | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Janssen Biotech
Send a request for any of these products. We confirm the licensed source, documents and lead time.